1.03

By Targets:	5-HT Receptor (3) Adenosine Receptor (1) Anaplastic lymphoma kinase (ALK) (1) Antibiotic (1) Apoptosis (7) ATM/ATR (1) Autophagy (2) Bacterial (10) Bcl-2 Family (6) Biochemical Assay Reagents (4) Bradykinin Receptor (1) c-Fms (1) c-Met/HGFR (1) Carbonic Anhydrase (1) Cathepsin (1) CCR (1) CD28 (2) CDK (1) Complement System (1) Cytochrome P450 (1) Dipeptidyl Peptidase (2) DNA Methyltransferase (1) DNA-PK (2) DNA/RNA Synthesis (1) EBI2/GPR183 (1) EGFR (2) Ferroptosis (3) FLAP (1) Fluorescent Dye (1) Fungal (3) G Protein-coupled Receptor Kinase (GRK) (1) GABA Receptor (1) Glucosidase (2) GnRH Receptor (2) HCV Protease (1) HDAC (4) HIV (14) HSP (1) IAP (1) iGluR (1) Influenza Virus (1) Isotope-Labeled Compounds (2) Ligands for E3 Ligase (2) LPL Receptor (3) MAGL (1) MAP4K (1) MDM-2/p53 (1) Melanocortin Receptor (1) MicroRNA (16) Molecular Glues (1) mTOR (2) Neurokinin Receptor (1) Notch (1) Opioid Receptor (1) PD-1/PD-L1 (1) Phosphodiesterase (PDE) (2) PI3K (2) PKC (1) PROTACs (1) RANKL/RANK (1) Ras (1) Reactive Oxygen Species (1) RET (1) Reverse Transcriptase (3) SARS-CoV (2) SGK (2) Small Interfering RNA (siRNA) (2) Sodium Channel (1) TAM Receptor (1) Thrombin (1) TNF Receptor (1) Topoisomerase (2) TRP Channel (3) YAP (2)
By Research Areas:	Cancer (49) Cardiovascular Disease (3) Endocrinology (2) Infection (29) Inflammation/Immunology (19) Metabolic Disease (10) Neurological Disease (17)

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-144876

RIDR-PI-103	Reactive Oxygen Species	Cancer
RIDR-PI-103 is a reactive oxygen species (ROS)-induced drug release prodrug with a self-cyclizing moiety linked to a pan-PI3K inhibitor (PI-103).

HY-10115

PI-103 Maximum Cited Publications 19 Publications Verification	PI3K mTOR DNA-PK Autophagy Apoptosis	Cancer
PI-103 is a potent PI3K and mTOR inhibitor with IC₅₀s of 8 nM, 88 nM, 48 nM, 150 nM, 20 nM, and 83 nM for p110α, p110β, p110δ, p110γ, mTORC1, and mTORC2. PI-103 also inhibits DNA-PK with an IC50 of 2 nM. PI-103 induces autophagy .

HY-10115A

*PI-103* Hydrochloride** Maximum Cited Publications 19 Publications Verification	PI3K mTOR DNA-PK Autophagy Apoptosis	Cancer
PI-103 Hydrochloride is a dual PI3K and mTOR inhibitor with IC₅₀s of 8 nM, 88 nM, 48 nM, 150 nM, 20 nM, and 83 nM for p110α, p110β, p110δ, p110γ, mTORC1, and mTORC2. PI-103 Hydrochloride also inhibits DNA-PK with an IC50 of 2 nM. PI-103 Hydrochloride induces autophagy .

HY-D1471

10-(3-Sulfopropyl)acridinium Betaine

Fluorescent Dye Others

10-(3-Sulfopropyl)acridinium Betaine is a fluorescent dye with high durability (>3 months) .

10-(3-Sulfopropyl)acridinium Betaine	Fluorescent Dye	Others
10-(3-Sulfopropyl)acridinium Betaine is a fluorescent dye with high durability (>3 months) .

HY-146470

Antibacterial agent 103	Bacterial	Infection
Antibacterial agent 103 (compound 7) has highly antibacterial activity against kinds of Gram-positive and -negative bacteria. Antibacterial agent 103 can be used for researching inhibition of resistance bacterial strains .

HY-155503

Antitumor agent-103	Apoptosis	Cancer
Antitumor agent-103 (compound 24l) is an apoptosis inducer with antiproliferative and anti-clony formation activities. Antitumor agent-103 arrests cell cycle at G0/G1 phase, enhances NO production, and exhibits anti-tumor activity .

HY-163354

EGFR-IN-103

EGFR Cancer

EGFR-IN-103 (compound 1) is a potent EGFR inhibitor with an IC₅₀ of 6 nM for pEGFR .
HY-149216

Anticancer agent 103

Others Cancer

Anticancer agent 103 (Compound 2k) is a potent anticancer agent .

EGFR-IN-103	EGFR	Cancer
EGFR-IN-103 (compound 1) is a potent EGFR inhibitor with an IC₅₀ of 6 nM for pEGFR .

Anticancer agent 103	Others	Cancer
Anticancer agent 103 (Compound 2k) is a potent anticancer agent .

HY-134955

VT103 2 Publications Verification	YAP	Cancer
VT103, an analog of VT101, is an orally active and selective TEAD1 protein palmitoylation inhibitor. VT103 inhibits YAP/TAZ-TEAD promoted gene transcription, blocks TEAD auto-palmitoylation, and disrupts interaction between YAP/TAZ and TEAD. VT103 can be used for the research of cancer .

HY-101203A

GJ103 sodium	Others	Metabolic Disease Cancer
GJ103 sodium is a read-through compound that can induce read through of premature stop codons. GJ103 sodium has potential for the research of genetic disorders caused by nonsense mutations .

HY-101203

GJ103
GJ103 is a read-through compound that can induce read through of premature stop codons. GJ103 has potential for the research of genetic disorders caused by nonsense mutations .

HY-13758A

*TAS-103* dihydrochloride** 1 Publications Verification BMS-247615 dihydrochloride	Topoisomerase	Cancer
TAS-103 dihydrochloride is a dual inhibitor of DNA topoisomerase I/II, used for cancer research.

HY-13758

TAS-103

BMS-247615
Topoisomerase Cancer

TAS-103 is a dual inhibitor of DNA topoisomerase I/II, used for cancer research.

TAS-103 BMS-247615	Topoisomerase	Cancer
TAS-103 is a dual inhibitor of DNA topoisomerase I/II, used for cancer research.

HY-P6053

KK-103	Opioid Receptor	Neurological Disease
KK-103 is a precursor of leucine-enkephalin (Leu-ENK) overcomes high proteolytic instability of Leu-ENK via markedly increased plasma stability in mice that has antinociceptive effect .

HY-117992

BR103	Complement System	Others
BR103 is a C3aR-specific small molecule ligand. BR103 can be used to measure ligand affinity for a G protein-coupled receptor for saturation and competitive binding .

HY-129118

Takeda103A	Others	Cardiovascular Disease
Takeda103A is a potent inhibitor of GRK2. G protein-coupled receptors (GPCRs) are central to many physiological processes. Takeda103A has the potential for the research of heart failure .

HY-152098

HX103	EGFR	Cancer
HX103 is an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI)-based fluorogenic probe. HX103 inhibits EGFR 19 del, EGFR L858R, EGFR wild type and EGFR T790M with IC₅₀s of 1.3, 1.5, 4.0 and 977 nM, respectively. HX103 can be used for quantifying active-EGFR to predict agent sensitivity in NSCLC patients with EGFR-activating mutations .

HY-135145

Limantrafin 5 Publications Verification CB-103	Notch	Cancer
Limantrafin (CB-103) is a first-in-class, orally active protein-protein interaction (PPI) inhibitor of the NOTCH transcriptional activation complex. Limantrafin has anti-tumor activity .

HY-14163

AM103

FLAP Inflammation/Immunology

AM 103 is a potent and selective FLAP inhibitor, with an IC₅₀ value of 4.2 nM.

AM103	FLAP	Inflammation/Immunology
AM 103 is a potent and selective FLAP inhibitor, with an IC₅₀ value of 4.2 nM.

HY-14557A

Pimavanserin hemitartrate 10+ Cited Publications ACP-103 hemitartrate	5-HT Receptor	Neurological Disease
Pimavanserin (ACP-103) hemitartrate is a potent 5-HT 2A receptor inverse agonist with pIC₅₀ and pK_i of 8.73 and 9.3, respectively.

HY-P99796

Ozoralizumab ATN-103	TNF Receptor	Inflammation/Immunology
Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis .

HY-P2499

*BAD (103-127) (human), FAM-labeled*	Bcl-2 Family	Cancer
BAD (103-127) (human), FAM-labeled is a FAM-labeled human BAD (103-127) (HY-P2468). BAD (103-127) (human), the 25-mer Bad peptide, is derived from the BH3 domain of BAD, can antagonize the function of Bcl-xL .

HY-15660

Efinaconazole 1 Publications Verification KP-103	Fungal	Infection
Efinaconazole (KP-103) is a triazole antifungal agent and againsts T. mentagrophytes SM-110 and C. albicans ATCC 10231 with MICs of 0.0039 μg/mL and 0.00098 μg/mL, respectively . Efinaconazole has a potent in vitro activity against fungal pathogens including dermatophytes, Candida and Malassezia species .

HY-P2468

*BAD (103-127) (human)* BADBH3 103-127 (human); BADBH3 (human)	Bcl-2 Family	Cancer
BAD (103-127) (human), the 25-mer Bad peptide, is derived from the BH3 domain of BAD, can antagonize the function of Bcl-xL. BAD (103-127) (human) is reported to have almost 800-fold higher affinity for Bcl-XL than the 16-mer peptide .

HY-157754

E3 Ligase Ligand-linker Conjugate 103	Ligands for E3 Ligase	Cancer
E3 Ligase Ligand-linker Conjugate 103 is a conjugate of E3 ligase ligand and linker, consisting of (S,R,S)-AHPC (HY-125845) and the corresponding Linker. (S,R,S)-AHPC is a VH032-based von Hippel-Lindau (VHL) ligand that recruits VHL proteins. E3 Ligase Ligand-linker Conjugate 103 can be used as a key intermediate for the synthesis of complete PROTAC molecules.

HY-R00040

*hsa-miR-103a-3p mimic*	MicroRNA	Cancer
hsa-miR-103a-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-103a-3p mimic hsa-miR-103a-3p mimic

HY-RS02024

CCDC103 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CCDC103 Human Pre-designed siRNA Set A contains three designed siRNAs for CCDC103 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCDC103 Human Pre-designed siRNA Set A CCDC103 Human Pre-designed siRNA Set A

HY-P1698

Reltecimod AB-103	Bacterial CD28	Infection Inflammation/Immunology
Reltecimod (AB-103) is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod can be used to research necrotizing soft-tissue infections (NSTIs) .

HY-R00038

*hsa-miR-103a-1-5p mimic*	MicroRNA	Cancer
hsa-miR-103a-1-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-103a-1-5p mimic hsa-miR-103a-1-5p mimic

HY-R00039

*hsa-miR-103a-2-5p mimic*	MicroRNA	Cancer
hsa-miR-103a-2-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-103a-2-5p mimic hsa-miR-103a-2-5p mimic

HY-RS03679

DEFB103A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
DEFB103A Human Pre-designed siRNA Set A contains three designed siRNAs for DEFB103A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DEFB103A Human Pre-designed siRNA Set A DEFB103A Human Pre-designed siRNA Set A

HY-P2291

*Beta-defensin 103* isoform X1, pig**	Bacterial	Inflammation/Immunology
Beta-defensin 103 isoform X1, pig is an antimicrobial peptide found in different living organisms, involved in the first line of defense in their innate immune response against pathogens .

HY-RI00040

*hsa-miR-103a-3p inhibitor*	MicroRNA
hsa-miR-103a-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-103a-3p inhibitor hsa-miR-103a-3p inhibitor

HY-P10132

*PRDX3(103-112), human*	Ferroptosis	Metabolic Disease
PRDX3(103-112), human is a marker for ferroptosis. PRDX3 is hyperoxidated by mitochondrial lipid peroxides. PRDX3 inhibits cystine uptake after hyperoxidization .

HY-P2291A

*Beta-defensin 103* isoform X1, pig TFA**	Bacterial	Inflammation/Immunology
Beta-defensin 103 isoform X1, pig TFA is an antimicrobial peptide found in different living organisms, involved in the first line of defense in their innate immune response against pathogens .

HY-P1698B

Reltecimod TFA AB-103 TFA	Bacterial CD28	Infection Inflammation/Immunology
Reltecimod (AB-103) TFA is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod TFA has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod TFA can be used to research necrotizing soft-tissue infections (NSTIs) .

HY-RI00038

*hsa-miR-103a-1-5p inhibitor*	MicroRNA
hsa-miR-103a-1-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-103a-1-5p inhibitor hsa-miR-103a-1-5p inhibitor

HY-RI00039

*hsa-miR-103a-2-5p inhibitor*	MicroRNA
hsa-miR-103a-2-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-103a-2-5p inhibitor hsa-miR-103a-2-5p inhibitor

HY-P10133

PRDX3(103-112) SO3 modified, human

Ferroptosis Metabolic Disease

PRDX3(103-112) SO3 modified, human is a marker of ferroptosis, and can be used for liver diseases study .

*PRDX3(103-112) SO3 modified, human*	Ferroptosis	Metabolic Disease
PRDX3(103-112) SO3 modified, human is a marker of ferroptosis, and can be used for liver diseases study .

HY-R00040A

*hsa-miR-103a-3p agomir*	MicroRNA
hsa-miR-103a-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-103a-3p agomir hsa-miR-103a-3p agomir

HY-15660S

Efinaconazole-d4 KP-103-d₄	Isotope-Labeled Compounds Fungal	Infection
Efinaconazole-d₄ is the deuterium labeled Efinaconazole. Efinaconazole (KP-103) is a triazole antifungal agent and againsts T. mentagrophytes SM-110 and C. albicans ATCC 10231 with MICs of 0.0039 μg/mL and 0.00098 μg/mL, respectively[1]. Efinaconazole has a potent in vitro activity against fungal pathogens including dermatophytes, Candida and Malassezia species[1].

HY-D1005A19

Poloxamer 333 (P103) PEG-PPG-PEG, 4950 (Averag)	Biochemical Assay Reagents Bacterial	Infection
Poloxamer 333 P103 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 4950. Poloxamer 333 P103 exhibits antimicrobial activity, that inihibits 90% Mycobacterium avium complex at concentration of 1 mg/mL. Poloxamer 333 P103 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering .

HY-R00038A

*hsa-miR-103a-1-5p agomir*	MicroRNA
hsa-miR-103a-1-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-103a-1-5p agomir hsa-miR-103a-1-5p agomir

HY-R00039A

*hsa-miR-103a-2-5p agomir*	MicroRNA
hsa-miR-103a-2-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-103a-2-5p agomir hsa-miR-103a-2-5p agomir

HY-R04208

*rno-miR-103-2-5p mimic*	MicroRNA	Cancer
rno-miR-103-2-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

rno-miR-103-2-5p mimic rno-miR-103-2-5p mimic

HY-RI00040A

*hsa-miR-103a-3p antagomir*	MicroRNA
hsa-miR-103a-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-103a-3p antagomir hsa-miR-103a-3p antagomir

HY-128311

GRK6-IN-3

G Protein-coupled Receptor Kinase (GRK) Inflammation/Immunology

GRK6-IN-3 is a G protein coupled receptor 6 kinase (GRK6) inhibitor with an IC₅₀ 1.03 μM .

HY-RI00038A

*hsa-miR-103a-1-5p antagomir*	MicroRNA
hsa-miR-103a-1-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-103a-1-5p antagomir hsa-miR-103a-1-5p antagomir

HY-RI00039A

*hsa-miR-103a-2-5p antagomir*	MicroRNA
hsa-miR-103a-2-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-103a-2-5p antagomir hsa-miR-103a-2-5p antagomir

HY-RI04208

*rno-miR-103-2-5p inhibitor*	MicroRNA
rno-miR-103-2-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-103-2-5p inhibitor rno-miR-103-2-5p inhibitor

Cat. No.	Product Name

HY-L103

Anti-Colorectal Cancer Compound Library

1618 compounds

Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, arises as adenocarcinoma from glandular epithelial cells of the large intestine comprised of the colon and rectum. The majority of cases of CRC are sporadic and result from risk factors, such as a sedentary lifestyle, obesity, processed diets, alcohol consumption and smoking. CRC is also a common preventable cancer.

Studies showed several cellular signaling pathways dysregulated in CRC, leading to the onset of malignant phenotypes. Therefore, it is necessary to analyze the signaling pathways involved in the occurrence and development of colorectal cancer to study the progression and drug treatment of colorectal cancer. Among them, Wnt/β-catenin, p53, TGF-β/SMAD, NF-κB, Notch, VEGF and other target genes and signaling pathways are the focus of research. MCE offers a unique collection of 1618 compounds with identified and potential anti-colorectal cancer activity. MCE anti-colorectal cancer compound library is a useful tool for anti-colorectal cancer drugs screening and other related research.

Cat. No.	Product Name	Type

HY-D1471

10-(3-Sulfopropyl)acridinium Betaine

Fluorescent Dyes/Probes

10-(3-Sulfopropyl)acridinium Betaine is a fluorescent dye with high durability (>3 months) .

Cat. No.	Product Name	Type

HY-D0870

CAPSO

Biochemical Assay Reagents

CAPSO is a biological zwitterionic buffer with the useful pH range from 8.9 to 10.3 .

HY-D1005A19

Poloxamer 333 (P103)

PEG-PPG-PEG, 4950 (Averag)

Co-solvents

Poloxamer 333 P103 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 4950. Poloxamer 333 P103 exhibits antimicrobial activity, that inihibits 90% Mycobacterium avium complex at concentration of 1 mg/mL. Poloxamer 333 P103 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering .

HY-D0870A

CAPSO sodium

Buffer Reagents

CAPSO sodium is a biological zwitterionic buffer with the useful pH range from 8.9 to 10.3 .

Cat. No.	Product Name	Target	Research Area

HY-P2468

*BAD (103-127) (human)* BADBH3 103-127 (human); BADBH3 (human)	Bcl-2 Family	Cancer
BAD (103-127) (human), the 25-mer Bad peptide, is derived from the BH3 domain of BAD, can antagonize the function of Bcl-xL. BAD (103-127) (human) is reported to have almost 800-fold higher affinity for Bcl-XL than the 16-mer peptide .

HY-P6053

KK-103	Opioid Receptor	Neurological Disease
KK-103 is a precursor of leucine-enkephalin (Leu-ENK) overcomes high proteolytic instability of Leu-ENK via markedly increased plasma stability in mice that has antinociceptive effect .

HY-P2499

*BAD (103-127) (human), FAM-labeled*	Bcl-2 Family	Cancer
BAD (103-127) (human), FAM-labeled is a FAM-labeled human BAD (103-127) (HY-P2468). BAD (103-127) (human), the 25-mer Bad peptide, is derived from the BH3 domain of BAD, can antagonize the function of Bcl-xL .

HY-P1698

Reltecimod AB-103	Bacterial CD28	Infection Inflammation/Immunology
Reltecimod (AB-103) is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod can be used to research necrotizing soft-tissue infections (NSTIs) .

HY-P2291

*Beta-defensin 103* isoform X1, pig**	Bacterial	Inflammation/Immunology
Beta-defensin 103 isoform X1, pig is an antimicrobial peptide found in different living organisms, involved in the first line of defense in their innate immune response against pathogens .

HY-P10132

*PRDX3(103-112), human*	Ferroptosis	Metabolic Disease
PRDX3(103-112), human is a marker for ferroptosis. PRDX3 is hyperoxidated by mitochondrial lipid peroxides. PRDX3 inhibits cystine uptake after hyperoxidization .

HY-P2291A

*Beta-defensin 103* isoform X1, pig TFA**	Bacterial	Inflammation/Immunology
Beta-defensin 103 isoform X1, pig TFA is an antimicrobial peptide found in different living organisms, involved in the first line of defense in their innate immune response against pathogens .

HY-P1698B

Reltecimod TFA AB-103 TFA	Bacterial CD28	Infection Inflammation/Immunology
Reltecimod (AB-103) TFA is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod TFA has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod TFA can be used to research necrotizing soft-tissue infections (NSTIs) .

HY-P1735

*Moth Cytochrome C (MCC) (88-103)*	Peptides	Inflammation/Immunology
Moth Cytochrome C (MCC) (88-103), derived from the carboxyl terminus of moth cytochrome c, induces positive selection of TCR transgenic thymocytes .

HY-P10133

PRDX3(103-112) SO3 modified, human

Ferroptosis Metabolic Disease

PRDX3(103-112) SO3 modified, human is a marker of ferroptosis, and can be used for liver diseases study .

HY-P1520

Prolactin Releasing Peptide (1-31), human	GnRH Receptor	Neurological Disease
Prolactin Releasing Peptide (1-31), human is a high affinity GPR10 ligand that cause the release of the prolactin. Prolactin Releasing Peptide (1-31) binds to GPR10 for human and rats with K_i values of 1.03 nM and 0.33 nM, respectively. Prolactin Releasing Peptide (1-31) can be used for the research of the hypothalamo-pituitary axis .

HY-P1520A

Prolactin Releasing Peptide (1-31), human acetate	GnRH Receptor	Neurological Disease
Prolactin Releasing Peptide (1-31), human (acetate) is a high affinity GPR10 ligand that causes the release of the prolactin. Prolactin Releasing Peptide (1-31) binds to GPR10 for human and rats with K_i values of 1.03 nM and 0.33 nM, respectively. Prolactin Releasing Peptide (1-31) can be used for the research of the hypothalamo-pituitary axis .

HY-P1915

26Rfa, Hypothalamic Peptide, human	Peptides	Metabolic Disease
26Rfa, Hypothalamic Peptide, human is a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity . 26RFa is an orexigenic neuropeptide identified as the endogenous ligand of the orphan G protein-coupled receptor GPR103 .

HY-P2472

Orphan GPCR SP9155 agonist P550 (mouse, rat) 26RFa (mouse, rat)	Peptides	Metabolic Disease
Orphan GPCR SP9155 agonist P550 (mouse, rat) (26RFa (mouse, rat)), a member of the RFamide peptide family with orexigenic effect, is the cognate ligand of the mouse orphan receptor GPR103, also designated SP9155 or AQ27 .

HY-103289

MEN 11270	Bradykinin Receptor	Metabolic Disease Inflammation/Immunology
MEN 11270, a cyclic decapeptide, is a B2 kinin receptor antagonist. MEN 11270 bound with high-affinity to the B2 kinin receptor constitutively expressed by WI38 human fibroblasts, inhibiting 3H-bradykinin (BK) with a pK_i value of 10.3 .

HY-P2454

CSP1	Bacterial	Infection
CSP1 is a potent and selective ComD1 receptor agonist, with an IC₅₀ of 10.3 nM. CSP1 is a major variants of competence-stimulating peptide (CSP), and it can regulate genetic transformation of S. pneumonia by modulating quorum sensing (QS). CSP1 can act as an antibacterial agent .

HY-P1705

Linopristin	Antibiotic Bacterial	Infection
Linopristin is a kind of type B streptogramin antibiotics. Linopristin, together with type A, Flopristin, to form the streptogramin combination NXL 103. Linopristin exhibit synergistic antimicrobial activity against certain pathogenic bacteria with Flopristin. The preference ratio of Linopristin/Flopristin is 30:70 (w/w) or 70 μM Linopristin +120 μM Flopristin .

Cat. No.	Product Name	Target	Research Area

HY-P99796

Ozoralizumab ATN-103	TNF Receptor	Inflammation/Immunology
Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis .

HY-P99795

Otilimab GSK 3196165; MOR103	c-Fms	Inflammation/Immunology
Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor .

HY-P990295

Anti-Mouse CD103 Antibody (M290)

Inhibitory Antibodies Others

Anti-Mouse CD103 Antibody (M290) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD103.
HY-P99966

Narlumosbart

RANKL/RANK Cancer

Narlumosbart (JMT103) is an IgG4κ antibody targeting receptor activator of nuclear factor-κB ligand (RANKL) .

HY-P99668

Iparomlimab	PD-1/PD-L1	Cancer
Iparomlimab is an anti-human PD-1/CD279/PDCD1 IgG4κ antibody. Iparomlimab also targets to human monoclonal PSB103 γ4-chain, disulfided with human monoclonal PSB103 κ-chain to form a dimer. Iparomlimab can be used for Oncology research .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N7203

N-Caffeoyl O-methyltyramine	Alkaloids Classification of Application Fields Source classification Phenols Polyphenols Metabolic Disease Plants Annonaceae Disease Research Fields Fissistigma oldhamii (Hemsl.) Merr.	Glucosidase
N-Caffeoyl O-methyltyramine is a class of alkaloid isolated from Cuscuta reflexa with strong inhibitory activity against α-glucosidase (IC₅₀ of 103.58 μM) .

HY-121811

Pongamol Lanceolatin C	Structural Classification Leguminosae Ketones, Aldehydes, Acids Source classification Derris trifoliata Lour. Plants Derris indica	Glucosidase
Pongamol (Lanceolatin C) is potent α-glucosidase inhibitor (IC₅₀=103.5 μM) and has free-radical (DPPH) scavenging,antihyperglycemic, and antihyperglycemic activities .

HY-N11570

Phaeocaulisin E	Structural Classification Terpenoids Sesquiterpenes Source classification Plants Curcuma phaeocaulis Valeton Zingiberaceae	Others
Phaeocaulisin E (Compound 5) is a guaiane-type sesquiterpene that inhibits LPS HY-(HY-D1056)-induced NO production in RAW 264.7 macrophages with an IC₅₀ of 10.3 μM .

Species:	Human (9) Virus (2) Mouse (4) Rat (1) Cynomolgus (4)
Tag:	His (8) Tag Free (7) Fc (5)
Source:	HEK293 (15) Sf9 insect cells (1) E. coli (4)

Cat. No.	Compare	Product Name	Species	Source

HY-P7137

	BD-3 Protein, Human rHuBD-3; DEFB-3; HBD3; Beta-defensin 103	Human	E. coli
	BD-3 Protein, Human is an antibacterial peptide that exhibits antibacterial activities towards Gram-negative and Gram-positive bacteria as well as an ability to act as a chemo-attractant.

HY-P7138

	BD-3 Protein, Mouse rMuBD-3; DEFB-3; HBD3; Beta-defensin 103	Mouse	E. coli
	BD-3 Protein, Mouse is an inducible antimicrobial peptide and exhibits broad-spectrum antimicrobial activity.

HY-P7139

BD-3 Protein, Rat

rRtBD-3; DEFB-3; HBD3; Beta-defensin 103
Rat E. coli

BD-3 Protein, Rat is an inducible antimicrobial peptide and exhibits broad-spectrum antimicrobial activity.

HY-P7794

	CD158d/KIR2DL4 Protein, Human (HEK293, His) rHuCD158d, His; Killer Cell Immunoglobulin-Like Receptor 2DL4; CD158 Antigen-Like Family Member D; KIR-103AS; MHC Class I NK Cell Receptor KIR103AS; CD158d; KIR2DL4; KIR103AS	Human	HEK293
	CD158d/KIR2DL4 Protein, Human (HEK293, His) is a recombinant human CD158d expressed in HEK 293 cells with a His tag at the N-terminus. CD158d/KIR2DL4 Protein is an NK cell-activating receptor with inhibitory potential.

HY-P75019

	HA/Hemagglutinin Protein, H7N7 (AAR02639, sf9, His) Influenza A H7N7 (A/chicken/Netherlands/1/03) Hemagglutinin / HA Protein (His)	Virus	Sf9 insect cells
	The hemagglutinin HA1 protein is essential for attachment of virions to host cells by binding to sialic acid-containing receptors, inducing virion internalization via clathrin-dependent or clathrin- and caveolin-independent pathways. As a class I viral fusion protein, HA1 determines host range restriction and virulence, mediating fusion between the virion membrane and the endosomal membrane. HA/Hemagglutinin Protein, H7N7 (AAR02639, sf9, His) is the recombinant Virus-derived HA/Hemagglutinin protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of HA/Hemagglutinin Protein, H7N7 (AAR02639, sf9, His) is 537 a.a., with molecular weight of ~59.4 kDa.

HY-P73143

	IgG1 Protein, Human (C103S, HEK293) Immunoglobulin heavy constant gamma 1; IGHG1	Human	HEK293
	The IgG1 protein is the constant region of the immunoglobulin heavy chain and serves as a receptor during the recognition phase of humoral immunity. It triggers clonal expansion and differentiation of B lymphocytes into immunoglobulin-secreting plasma cells. IgG1 Protein, Human (C103S, HEK293) is the recombinant human-derived IgG1 protein, expressed by HEK293 , with tag free. The total length of IgG1 Protein, Human (C103S, HEK293) is 232 a.a., with molecular weight of approximately 34 kDa.

HY-P74922

	HA1/Hemagglutinin Protein, H7N7 (AAR02639, HEK293, His) Influenza A H7N7 (A/chicken/Netherlands/1/03) Hemagglutinin Protein (HA1 Subunit) (His)	Virus	HEK293
	The hemagglutinin HA1 protein is essential for attachment of virions to host cells by binding to sialic acid-containing receptors, inducing virion internalization via clathrin-dependent or clathrin- and caveolin-independent pathways. As a class I viral fusion protein, HA1 determines host range restriction and virulence, mediating fusion between the virion membrane and the endosomal membrane. HA1/Hemagglutinin Protein, H7N7 (AAR02639, HEK293, His) is the recombinant Virus-derived HA1/Hemagglutinin protein, expressed by HEK293 , with C-His labeled tag. The total length of HA1/Hemagglutinin Protein, H7N7 (AAR02639, HEK293, His) is 344 a.a., with molecular weight of ~47 kDa.

HY-P77526

	IgG1 Protein, Human (Biotinylated, C103S, HEK293) Immunoglobulin heavy constant gamma 1; IGHG1	Human	HEK293
	The IgG1 protein is the constant region of the immunoglobulin heavy chain and serves as a receptor during the recognition phase of humoral immunity. It triggers clonal expansion and differentiation of B lymphocytes into immunoglobulin-secreting plasma cells. IgG1 Protein, Human (Biotinylated, C103S, HEK293) is the recombinant human-derived IgG1 protein, expressed by HEK293 , with tag free. The total length of IgG1 Protein, Human (Biotinylated, C103S, HEK293) is 232 a.a., with molecular weight of ~26.1 KDa.

HY-P77733

	LAMP5 Protein, Mouse (HEK293, Fc) BAD-LAMP; LAMP-5; BADLAMP; C20orf103; dJ1119D9.3; UNC-43	Mouse	HEK293
	LAMP5 Protein significantly contributes to short-term synaptic plasticity in a specific subset of GABAergic neurons in the brain. LAMP5 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived LAMP5 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of LAMP5 Protein, Mouse (HEK293, Fc) is 206 a.a., with molecular weight of 60-70 kDa.

HY-P700774

	LAMP5 Protein, Cynomolgus (HEK293, His) BAD-LAMP; LAMP-5; BADLAMP; C20orf103; dJ1119D9.3; UNC-43	Cynomolgus	HEK293
	LAMP5 Protein, a member of the LAMP family, is delineated. LAMP5 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived LAMP5 protein, expressed by HEK293, with C-His labeled tag. The total length of LAMP5 Protein, Cynomolgus (HEK293, His) is 206 a.a., with molecular weight of 30-40 kDa.

HY-P77978

	LAMP5/BAD-LAMP Protein, Human (HEK293, Fc) BAD-LAMP; LAMP-5; BADLAMP; C20orf103; dJ1119D9.3; UNC-43	Human	HEK293
	LAMP5/BAD-LAMP protein plays a role in short-term synaptic plasticity within a specific subset of GABAergic neurons in the brain. LAMP5/BAD-LAMP Protein, Human (HEK293, Fc) is the recombinant human-derived LAMP5/BAD-LAMP protein, expressed by HEK293 , with C-hFc labeled tag. The total length of LAMP5/BAD-LAMP Protein, Human (HEK293, Fc) is 206 a.a., with molecular weight of 60-70 kDa.

HY-P700775

	LAMP5/BAD-LAMP Protein, Human (HEK293, His) BAD-LAMP; LAMP-5; BADLAMP; C20orf103; dJ1119D9.3; UNC-43	Human	HEK293
	LAMP5/BAD-LAMP protein plays a role in short-term synaptic plasticity within a specific subset of GABAergic neurons in the brain. LAMP5/BAD-LAMP Protein, Human (HEK293, His) is the recombinant human-derived LAMP5/BAD-LAMP protein, expressed by HEK293 , with C-His labeled tag. The total length of LAMP5/BAD-LAMP Protein, Human (HEK293, His) is 206 a.a., with molecular weight of 30-40 kDa.

HY-P72975

	CD26/Dipeptidyl Peptidase 4 Protein, Human (HEK293) Dipeptidyl peptidase 4; ADABP; ADCP-2; DPP IV; TP103; CD26; DPP4	Human	HEK293
	The CD26/dipeptidyl peptidase 4 protein is a cell surface glycoprotein receptor that induces T cell proliferation and NF-kappa-B activation. CD26 also works with FAP to promote pericellular proteolysis, endothelial cell migration, and invasion of the extracellular matrix. CD26/Dipeptidyl Peptidase 4 Protein, Human (HEK293) is the recombinant human-derived CD26/Dipeptidyl Peptidase 4 protein, expressed by HEK293 , with tag free. The total length of CD26/Dipeptidyl Peptidase 4 Protein, Human (HEK293) is 738 a.a., with molecular weight of ~95 kDa.

HY-P76875

	CD26/Dipeptidyl Peptidase 4 Protein, Cynomolgus (HEK293) Dipeptidyl peptidase 4; ADABP; ADCP-2; DPP IV; TP103; CD26; DPP4	Cynomolgus	HEK293
	CD26/Dipeptidyl Peptidase 4 Protein is a serine membrane anchored exopeptidase, belonging to dipeptidyl peptidase (DPP) family. CD26/Dipeptidyl Peptidase 4 Protein is widely expressed in a variety of tissues and many cells. CD26/Dipeptidyl Peptidase 4 Protein, Cynomolgus (HEK293) is the recombinant cynomolgus-derived CD26/Dipeptidyl Peptidase 4 protein, expressed by HEK293 , with tag free. The total length of CD26/Dipeptidyl Peptidase 4 Protein, Cynomolgus (HEK293) is 733 a.a., with molecular weight of 92-102 kDa.

HY-P72976

	CD26/Dipeptidyl Peptidase 4 Protein, Human (HEK293, Fc) Dipeptidyl peptidase 4; ADABP; ADCP-2; DPP IV; TP103; CD26; DPP4	Human	HEK293
	The CD26/dipeptidyl peptidase 4 protein is a cell surface glycoprotein receptor that induces T cell proliferation and NF-kappa-B activation. CD26 also works with FAP to promote pericellular proteolysis, endothelial cell migration, and invasion of the extracellular matrix. CD26/Dipeptidyl Peptidase 4 Protein, Human (HEK293, Fc) is the recombinant human-derived CD26/Dipeptidyl Peptidase 4 protein, expressed by HEK293 , with N-hFc labeled tag. The total length of CD26/Dipeptidyl Peptidase 4 Protein, Human (HEK293, Fc) is 738 a.a., with molecular weight of 120-130 kDa.

HY-P75428

	CD26/Dipeptidyl Peptidase 4 Protein, Mouse (HEK293, His) Dipeptidyl peptidase 4; ADABP; ADCP-2; DPP IV; TP103; CD26; DPP4	Mouse	HEK293
	CD26/dipeptidyl peptidase 4 is a key cell surface receptor for T cell activation. It binds to ADA, CAV1, IGF2R and PTPRC to promote T cell proliferation and NF-kappa-B activation. CD26/Dipeptidyl Peptidase 4 Protein, Mouse (HEK293, His) is the recombinant mouse-derived CD26/Dipeptidyl Peptidase 4 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD26/Dipeptidyl Peptidase 4 Protein, Mouse (HEK293, His) is 732 a.a., with molecular weight of ~85.9 kDa.

HY-P75429

	CD26/Dipeptidyl Peptidase 4 Protein, Mouse (HEK293, Fc) Dipeptidyl peptidase 4; ADABP; ADCP-2; DPP IV; TP103; CD26; DPP4	Mouse	HEK293
	CD26/dipeptidyl peptidase 4 is a key cell surface receptor for T cell activation. It binds to ADA, CAV1, IGF2R and PTPRC to promote T cell proliferation and NF-kappa-B activation. CD26/Dipeptidyl Peptidase 4 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived CD26/Dipeptidyl Peptidase 4 protein, expressed by HEK293 , with N-hFc labeled tag. The total length of CD26/Dipeptidyl Peptidase 4 Protein, Mouse (HEK293, Fc) is 732 a.a., with molecular weight of ~122.5 kDa.

HY-P76876

	CD26/Dipeptidyl Peptidase 4 Protein, Cynomolgus (HEK293, His) Dipeptidyl peptidase 4; ADABP; ADCP-2; DPP IV; TP103; CD26; DPP4	Cynomolgus	HEK293
	CD26/Dipeptidyl Peptidase 4 Protein is a serine membrane anchored exopeptidase, belonging to dipeptidyl peptidase (DPP) family. CD26/Dipeptidyl Peptidase 4 Protein is widely expressed in a variety of tissues and many cells. CD26/Dipeptidyl Peptidase 4 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived CD26/Dipeptidyl Peptidase 4 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD26/Dipeptidyl Peptidase 4 Protein, Cynomolgus (HEK293, His) is 733 a.a., with molecular weight of 100-130 KDa.

HY-P76877

	CD26/Dipeptidyl Peptidase 4 Protein, Cynomolgus (HEK293, Fc) Dipeptidyl peptidase 4; ADABP; ADCP-2; DPP IV; TP103; CD26; DPP4	Cynomolgus	HEK293
	CD26/Dipeptidyl Peptidase 4 Protein is a serine membrane anchored exopeptidase, belonging to dipeptidyl peptidase (DPP) family. CD26/Dipeptidyl Peptidase 4 Protein is widely expressed in a variety of tissues and many cells. CD26/Dipeptidyl Peptidase 4 Protein, Cynomolgus (HEK293, Fc) is the recombinant cynomolgus-derived CD26/Dipeptidyl Peptidase 4 protein, expressed by HEK293 , with N-hFc labeled tag. The total length of CD26/Dipeptidyl Peptidase 4 Protein, Cynomolgus (HEK293, Fc) is 733 a.a., with molecular weight of ~113 kDa.

HY-P72166

	*DBI Protein, Human (103a.a, His)* ACBD1; ACBP; ACBP_HUMAN; Acyl CoA binding domain containing 1; Acyl CoA binding protein; Acyl Coenzyme A binding domain containing 1; Acyl coenzyme A binding protein; Acyl-CoA-binding protein; CCK RP; CCKRP; Cholecystokinin releasing peptide trypsin sensitive; DBI; Diazepam-binding inhibitor; Endozepine; EP; GABA receptor modulator; MGC70414	Human	E. coli
	DBI, a versatile protein, binds medium- and long-chain acyl-CoA esters, indicating a potential intracellular carrier role. It also displaces diazepam from the benzodiazepine recognition site on the GABA type A receptor. This dual functionality suggests DBI may act as a neuropeptide, modulating GABA receptor activity. Remarkably, DBI functions as a monomer in these interactions. DBI Protein, Human (103a.a, His) is the recombinant human-derived DBI protein, expressed by E. coli , with N-6*His labeled tag. The total length of DBI Protein, Human (103a.a, His) is 103 a.a., with molecular weight of ~14 kDa.

Cat. No.	Product Name	Chemical Structure

HY-15660S

Efinaconazole-d4
Efinaconazole-d₄ is the deuterium labeled Efinaconazole. Efinaconazole (KP-103) is a triazole antifungal agent and againsts T. mentagrophytes SM-110 and C. albicans ATCC 10231 with MICs of 0.0039 μg/mL and 0.00098 μg/mL, respectively[1]. Efinaconazole has a potent in vitro activity against fungal pathogens including dermatophytes, Candida and Malassezia species[1].

HY-117605S

N-Desmethyl Sildenafil-d8
N-Desmethyl Sildenafil-d₈ is the deuterium labeled N-Desmethyl Sildenafil (HY-117605). N-Desmethyl Sildenafil is a major metabolite of Sildenafil. Sildenafil is a potent phosphodiesterase type 5 (PDE5) inhibitor[1][2][3].

Cat. No.	Product Name	Application	Reactivity

HY-P82318

SRP72 Antibody (YA2063)

BMFF; BMFS1; HEL103
WB, IHC-F, IHC-P, ICC/IF Human
HY-P81498

CD103 Antibody (YA1243)

Integrin alpha-E; HML-1 antigen; Integrin alpha-IEL; Mucosal lymphocyte 1 antigen; CD103; ITGAE; Integrin alpha E
IHC-P Human
HY-P82933

Gemin 3 Antibody (YA2678)

ddx20; DP103; Gemin3; SMN interacting protein
WB, IHC-P, ICC/IF, FC Human, Mouse
HY-P83306

Integrin alpha E Antibody (YA3051)

Integrin alpha-E; HML-1 antigen; Integrin alpha-IEL; Mucosal lymphocyte 1 antigen; CD103; ITGAE
IHC-P Human

HY-P81529

DPP4/CD26 Antibody (YA1274) ADCP2, CD26; DPP4; Dipeptidyl peptidase 4; ADABP; Adenosine deaminase complexing protein 2 (ADCP-2); Dipeptidyl peptidase IV (DPP IV); T-cell activation antigen CD26; TP103	IHC-P	Human

HY-P82766

CD26 Antibody (YA2511) DPP4; ADCP2; CD26; Dipeptidyl peptidase 4; ADABP; Adenosine deaminase complexing protein 2; ADCP-2; Dipeptidyl peptidase IV; DPP IV; T-cell activation antigen CD26; TP103; CD26	WB	Human, Mouse, Rat


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Screening Libraries

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies